anti-angiogenic peptide antigen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-angiogenic peptide antigen, covering 2013-08-15 to 2013-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer [Phase 1]